RAP 0.00% 20.5¢ resapp health limited

Good news: fund available for 2nd study, case by case study on...

  1. 392 Posts.
    lightbulb Created with Sketch. 1
    Good news: fund available for 2nd study, case by case study on all results, working closely with hospitals
    bad news: no timeline but hope to set dates end of this month

    also revise algo, improvements identified, over 1200 sets which will improve data, same group of hospitals for pediatric trial

    Australian adult studies in parallel, 8.5 million cash in bank for all trials
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.